• This is a political forum that is non-biased/non-partisan and treats every person's position on topics equally. This debate forum is not aligned to any political party. In today's politics, many ideas are split between and even within all the political parties. Often we find ourselves agreeing on one platform but some topics break our mold. We are here to discuss them in a civil political debate. If this is your first visit to our political forums, be sure to check out the RULES. Registering for debate politics is necessary before posting. Register today to participate - it's free!

Germany boosts own vaccine makers in race for COVID-19 jab

JacksinPA

Supporting Member
DP Veteran
Monthly Donator
Joined
Dec 3, 2017
Messages
26,290
Reaction score
16,771
Gender
Male
Political Leaning
Progressive
Germany boosts own vaccine makers in race for COVID-19 jab

BERLIN (AP) — Germany says it is providing up to 750 million euros ($892 million) to support three domestic pharmaceutical companies that are developing vaccines against the new coronavirus.

Science Minister Anja Karliczek said Tuesday that the government has already agreed to provide BioNTech and CureVac with 375 million euros and 230-million euros respectively to develop their mRNA-based vaccines.

Talks with a third company, IDT Biologika, are expected to conclude soon, she said. The company is developing a vector-based vaccine that delivers a coronavirus protein into cells to stimulate the body’s immune response.
========================================================
It's hard to keep track of all the vaccine developers.
 
Germany boosts own vaccine makers in race for COVID-19 jab

BERLIN (AP) — Germany says it is providing up to 750 million euros ($892 million) to support three domestic pharmaceutical companies that are developing vaccines against the new coronavirus.

Science Minister Anja Karliczek said Tuesday that the government has already agreed to provide BioNTech and CureVac with 375 million euros and 230-million euros respectively to develop their mRNA-based vaccines.

Talks with a third company, IDT Biologika, are expected to conclude soon, she said. The company is developing a vector-based vaccine that delivers a coronavirus protein into cells to stimulate the body’s immune response.
========================================================
It's hard to keep track of all the vaccine developers.

All good. The more the better.
 
Back
Top Bottom